ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 215 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,804,000 | -47.2% | 44,629 | -24.8% | 0.03% | -50.8% |
| Q2 2015 | $3,415,000 | +253.5% | 59,336 | +291.3% | 0.06% | +205.0% |
| Q1 2015 | $966,000 | -10.1% | 15,165 | -12.9% | 0.02% | +11.1% |
| Q4 2014 | $1,075,000 | +283.9% | 17,414 | +141.8% | 0.02% | +260.0% |
| Q3 2014 | $280,000 | -48.2% | 7,202 | -50.0% | 0.01% | -28.6% |
| Q3 2013 | $541,000 | – | 14,415 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |